Free flap failure secondary to dual thrombophilia

Microsurgery

Volumn 29, Issue 1, 2009, Pages 62-65

  Davis, Michael Robert ^a   Daniel Huff Shell, I V ^a   Marques, Marisa ^b   Long, James Neal ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; DEXTRAN; HEPARIN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; EXTERNAL FIXATOR; FREE TISSUE GRAFT; GRAFT FAILURE; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; LEG FRACTURE; MALE; MICROSURGERY; OPEN REDUCTION; OSTEOSYNTHESIS; PRIORITY JOURNAL; THROMBOPHILIA; TRAFFIC ACCIDENT;

FACTOR VIII; GRAFT SURVIVAL; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LEG; MALE; MICROSURGERY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS; THROMBOPHILIA; THROMBOSIS; ULTRASONOGRAPHY, DOPPLER;

EID: 58849088566     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20553     Document Type: Article

References (23)

1. Virchow R. Phlogose und Thrombose im gefäβsystem: Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt, Germany: Staatsdruckerei; 1856.
2. Bertina R, Koeleman B, Koster T, Rosendaal F, Dirven R, de Ronde H, van der Velden P, Reitsma P. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
3. Poort S, Rosendaal F, Reitsma P, Bertina R. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
4. Egeberg O. Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516-530.
5. Griffin J, Evatt B, Zimmerman T, Kleiss A, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68: 1370-1373.
6. Schwarz H, Fischer M, Hopmeier P, Batard M, Griffin J. Plasma protein S deficiency in familial thrombotic disease. Blood 1984;64:1297-1300.
7. Kamphuisen P, Eikenboom J, Bertina R. Elevated Factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001;21: 731-738.
8. Koster T, Rosendaal F, Reitsma P, van der Velden P, Briet E, Van-denbroucke J. Factor VII and fibrinogen levels as risk factors for venous thrombosis: A case-control study of plasma levels and DNA polymorphisms: The Leiden Thrombophilia Study (LETS). Thromb Haemost 1994;71:719-722.
9. Khamashta M, Cuadrado M, Mujic F, Taub N, Hunt B, Hughes G. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1985;332:993-997.
10. Boushey C, Beresford S, Omenn G, Motnisky A. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intake. JAMA 1995;274:1049-1057.
11. den Heijer M, Koster T, Blom H, Bos G, Briët E, Reitsma P, Vanden- broucke J, Rosendaal F. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-762.
12. Ueland P, Refsum H. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
13. Kang S, Wong P, Malinow M. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-298.
14. Welch G, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-1050.
15. Wald D, Law M, Morris J. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002;325: 1202.
16. Kraaijenhagen R, Anker P, Koopman M, Reitsma P, Prins M, van den Ende A, Buller H. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
17. Egeberg O. Clotting factor levels in patients with coronary atherosclerosis. Scand J Clin Lab Invest 1962;14:253-258.
18. Ørstavik K, Magnus P, Reisner H, Berg K, Graham J, Nance W. Factor VIII and factor IX in a twin population: Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37:89-101.
19. Koster T, Blann A, Briët E, Vandenbroucke J, Rosendaal F. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-155.
20. Kyrle P, Minar E, Hirschl M, Bialonczyck C, Stain M, Schneider B, Weltermann A, Speiser W, Lechner K, Eichinger S. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-462.
21. Shaw R, Rogers S. Venous microvascular anastomotic failure due to prothrombin gene mutation. Plast Reconstr Surg 2005;115:1451- 1452.
22. Arnjolts B, Soderstrom B, Svensson H. No correlation between activated protein C resistance and free flap failures in 100 consecutive patients. Plast Reconstr Surg 1998;101:1850-1853.
23. Antonijevic N, Stanojevic M, Milosevic R, Djordjevic V, Jaukovic M, Vukcevic V, Kovac M, Mikovic D, Radojkovic D, Vasiljevic Z. Combined thrombophilic risk factors and essential thrombocythemia in patient with recurrent venous thromboembolic episodes-Thirty-three year follow-up. J Thromb Thrombolysis 2005;19:93-95.